Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Exp Eye Res. 2009 Oct 28;90(1):146–154. doi: 10.1016/j.exer.2009.10.001

Figure 1.

Figure 1

Structures of the physiologic agonist adenosine, the A3-selective agonist Cl-IB-MECA and the A3-antagonist nucleoside derivatives, MRS 3771, LJ 979, MRS 3826, MRS 3827 and LJ 1251.